Tumor regression grading in rectal cancer: Is it time to move forward?

Journal of Clinical Oncology

Volumn 32, Issue 15, 2014, Pages 1534-1536

  Valentini, Vincenzo ^a   Minsky, Bruce D ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; EDITORIAL; FOLLOW UP; HUMAN; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RECTUM SURGERY; TRANSRECTAL ULTRASONOGRAPHY; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; CARCINOMA; FEMALE; MALE; NOTE; RECTUM TUMOR;

CARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; NEOADJUVANT THERAPY; RECTAL NEOPLASMS;

EID: 84903779779     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.4766     Document Type: Editorial

References (18)

1. Sargent DJ, Patiyil S, Yothers G, et al: End points for colon cancer adjuvant trials: Observations and recommendations based on individual patient data from 20,898 patients enrolled onto randomized trials from the ACCENT Group. J Clin Oncol 25:4569-4574, 2007 (Pubitemid 350035314)
2. Fokas E, Liersch T, Fietkau R, et al: Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: Updated results of the CAO/ARO/AIO-94 trial. J Clin Oncol 32:1554-1562, 2014
3. Bonnetain F, Bosset JF, Gerard JP, et al: What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: Surrogacy in question? Eur J Cancer 48:1781-1790, 2012
4. Valentini V, Cellini F, Barba MC, et al: Do Different Populations of Rectal Cancer Exist? in Valentini V, Schmoll HJ, van de Velde CJH (eds): Multidisciplinary Management of Rectal Cancer Questions and Answers, Berlin Heidelberg, Germany, Springer-Verlag, 2012, pp 49-55
5. Dworak O, Keilholz L, Hoffmann A: Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19-23, 1997 (Pubitemid 27138353)
6. Quirke P, Williams GT. Minimum Dataset for Colorectal Cancer Histopathology Reports. London, United Kingdom, Royal College of Pathologists, 1998, pp 1-27
7. Washington MK, Berlin J, Branton P, et al: Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 133:1539-1551, 2009
8. Vecchio FM, Valentini V, Minsky BD, et al: The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62:752-760, 2005 (Pubitemid 40779765)
9. Huebner M, Wolff BG, Smyrk TC, et al: Partial pathologic response and nodal status as most significant prognostic factors for advanced rectal cancer treated with preoperative chemoradiotherapy. World J Surg 36:675-683, 2012
10. Pucciarelli S, De Paoli A, Guerrieri M, et al: Local excision after preoperative chemoradiotherapy for rectal cancer: Results of a multicenter phase II clinical trial. Dis Colon Rectum 56:1349-1356, 2013
11. Habr-Gama A, Sabbaga J, Gama-Rodrigues J, et al: Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: Are we getting closer to anal cancer management? Dis Colon Rectum 56:1109-1117, 2013
12. Maas M, Beets-Tan RGH, Lambregts DMJ, et al: Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 29:4633-4640, 2011
13. Coco C, Rizzo G, Mattana C, et al: Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: Short-term morbidity and functional outcome. Surg Endosc 27:2860-2867, 2013
14. van Stiphout RG, Lammering G, Buijsen J, et al: Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. Radiother Oncol 98:126-133, 2011
15. Bosset JF, Collette L, Bardet E, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006 (Pubitemid 44394918)
16. Valentini V, van Stiphout RGPM, Lammering G, et al: Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: Results of a phase II study. J Clin Oncol 29:3163-3172, 2011
17. van de Velde CJ, Boelens PG, Borras JM, et al: EURECCA colorectal: Multidisciplinary management - European consensus conference colon & rectum. Eur J Cancer 50:1.e1-1.e34, 2014
18. Lambin P, van Stiphout RG, Starmans MH, et al: Predicting outcomes in radiation oncology: Multifactorial decision support systems. Nat Rev Clin Oncol 10:27-40, 2013